What the internist should know about stem cell transplant in the elderly patient.
Sign Up to like & getrecommendations! Published in 2018 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2018.06.018
Abstract: Most hematological malignancies are increasing in frequency with age. Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapeutic option for patients with malignant and non-malignant hematological diseases. The treatment of elderly patients with advanced… read more here.
Keywords: allo hct; internist know; know stem; stem cell ... See more keywords